Bryan Smith Selected Research

neonatal Fc receptor

1/2021	Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
1/2020	Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice.
11/2017	The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bryan Smith Research Topics

Disease

13	Malaria 01/2019 - 12/2010
6	Heart Failure 05/2020 - 01/2019
4	Stroke (Strokes) 01/2022 - 05/2013
4	Falciparum Malaria (Plasmodium falciparum Malaria) 07/2014 - 12/2010
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 11/2017
3	Body Weight (Weight, Body) 01/2019 - 11/2012
3	Infections 11/2017 - 10/2016
2	Multiple Sclerosis 01/2022 - 02/2019
2	Nausea 01/2022 - 05/2017
2	Hemorrhage 01/2022 - 10/2018
2	Thrombosis (Thrombus) 04/2020 - 01/2020
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 10/2018
2	Parasitemia 01/2019 - 11/2012
2	Myasthenia Gravis 10/2018 - 11/2016
2	Asthma (Bronchial Asthma) 01/2018 - 01/2013
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Primary Graft Dysfunction 01/2022
1	Neuromyelitis Optica (Devic's Disease) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Hearing Loss (Hearing Impairment) 04/2021
1	Diseases Newborn Infant 01/2021
1	Arthrogryposis 01/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Neoplasms (Cancer) 12/2020
1	Hyponatremia 01/2020
1	Hypernatremia 01/2020
1	Systolic Heart Failure 01/2020
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2020
1	Right Ventricular Dysfunction 01/2020
1	Pemphigus (Pemphigus Vulgaris) 01/2020
1	Bullous Pemphigoid (Pemphigoid) 01/2020
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 12/2019
1	Insulin Resistance 11/2019
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 02/2019
1	Neuroinflammatory Diseases 02/2019
1	Progressive Multifocal Leukoencephalopathy 01/2019
1	Hemolysis 01/2019
1	Hyperbilirubinemia 01/2019
1	Inflammation (Inflammations) 10/2018
1	Sudden Death 12/2017
1	Gastroenteritis 05/2017
1	Neck Pain (Cervicalgia) 05/2017
1	Vomiting 05/2017
1	Diarrhea 05/2017
1	Opportunistic Infections (Opportunistic Infection) 10/2016

Drug/Important Bio-Agent (IBA)

8	tafenoquineIBA 01/2022 - 02/2014
7	ArtesunateIBA 01/2019 - 12/2010
6	Immunoglobulin G (IgG)IBA 01/2022 - 11/2017
5	Pharmaceutical PreparationsIBA 05/2017 - 12/2010
4	AntibodiesIBA 01/2021 - 11/2016
4	AutoantibodiesIBA 01/2020 - 11/2016
4	Antimalarials (Antimalarial Agents)IBA 01/2019 - 02/2014
3	neonatal Fc receptorIBA 01/2021 - 11/2017
3	artemisinin (artemisinine)IBA 01/2019 - 01/2011
3	Primaquine FDA Link 11/2015 - 02/2014
3	Mefloquine (Lariam)FDA LinkGeneric 11/2015 - 09/2011
2	Monoclonal AntibodiesIBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2019
2	Hemoglobins (Hemoglobin)IBA 11/2019 - 01/2019
2	Quinine (Quinson)FDA Link 01/2019 - 12/2010
2	rozanolixizumabIBA 10/2018 - 11/2017
2	AllergensIBA 01/2018 - 01/2013
1	EpitopesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Fc Receptors (Fc Receptor)IBA 01/2022
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022
1	Oligoclonal BandsIBA 04/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 12/2020
1	Therapeutic UsesIBA 01/2020
1	SodiumIBA 01/2020
1	Tolvaptan FDA Link 01/2020
1	Testosterone (Sustanon)FDA Link 11/2019
1	butyl phosphorotrithioate (DEF)IBA 02/2019
1	Protons (Proton)IBA 02/2019
1	Inosine Triphosphate (ITP)IBA 01/2019
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2019
1	pembrolizumabIBA 01/2019
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2019
1	Immunoglobulin FragmentsIBA 01/2018
1	Immunoglobulin Fab FragmentsIBA 01/2018
1	CytokinesIBA 01/2018
1	Interleukin-13IBA 01/2018
1	EnzymesIBA 01/2017
1	8-aminoquinolineIBA 01/2017
1	VaccinesIBA 11/2016
1	Immunoglobulins (Immunoglobulin)IBA 11/2016

Therapy/Procedure

13	Therapeutics 04/2020 - 12/2009
9	Heart-Assist Devices 05/2020 - 10/2018
1	Extracorporeal Membrane Oxygenation 01/2022
1	Heart Transplantation (Grafting, Heart) 01/2021
1	Transplantation 01/2021
1	Cannula 01/2020
1	Chemoprevention 01/2019
1	Patient Readmission 01/2019
1	Secondary Prevention 12/2017
1	Plasma Exchange 11/2016
1	Art Therapy 10/2016